Digital Content 
NEWS #PharmaBuzz
04 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/04/2892922/15991/en/Amicus-Therapeutics-Receives-Prix-Galien-U-K-Award-for-Pombiliti-cipaglucosidase-alfa-Opfolda-miglustat-as-Best-Pharmaceutical-Product.html
01 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/pantherxrare-selected-by-edenbridge-pharmaceuticals-as-specialty-pharmacy-for-yargesa-miglustat-100-mg-capsules-302104863.html
08 Feb 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/02/08/2825867/15991/en/Amicus-Therapeutics-Receives-the-2024-New-Treatment-Award-for-Pombiliti-cipaglucosidase-alfa-atga-Opfolda-miglustat-at-the-20th-Annual-WORLDSymposium.html
29 Sep 2023
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-amicus-therapeutics-muscle-disorder-treatment-2023-09-28/
16 Aug 2023
// BENZINGA
https://www.benzinga.com/pressreleases/23/08/g33854613/amicus-therapeutics-announces-approval-and-launch-of-new-pompe-disease-therapy-in-the-united-kingd
07 Jul 2023
// EMA
https://www.ema.europa.eu/en/documents/overview/opfolda-epar-medicine-overview_en.pdf
Share 